Crospovidone
11 organisations hold 11 active FDA Type IV Drug Master Files for Crospovidone. 8 valid EDQM Certificates of Suitability are on record for the same substance.
Sources: FDA List of Drug Master Files (checked 13 Nov 2026); FDA Global Substance Registration System (identity); EDQM Certification Online Database. Methodology
Active Type IV DMFs (11)
| Holder | DMF | Filed as | Submitted |
|---|---|---|---|
| JIANGXI ALPHA HI-TECH PHARMACEUTICAL CO LTD | 42983 | CROSPOVIDONE | Dec 2025 |
| ZHEJIANG RETRON BIOTECH CO LTD | 41056 | CROSPOVIDONE | Dec 2024 |
| G.C. CHEMIE PHARMIE LTD | 40086 | CROSPOVIDONE | Jun 2024 |
| SHANGHAI YUKING WATER SOLUBLE MATERIAL TECH CO LTD China | 38724 | CROSPOVIDONE | Aug 2023 |
| ALCEDO PHARMACHEM PRIVATE LTD | 36620 | CROSPOVIDONE USP-NF | Dec 2021 |
| BOAI NKY MEDICAL HOLDINGS LTD China | 35341 | CROSPOVIDONE | Dec 2020 |
| ANHUI SUNHERE PHARMACEUTICAL EXCIPIENTS CO LTD | 34076 | CROSPOVIDONE | Sept 2019 |
| CNSG ANHUI HONG SIFANG CO LTD | 30700 | CROSPOVIDONE | May 2016 |
| HUANGSHAN BONSUN PHARMACEUTICALS CO LTD | 29013 | CROSPOVIDONE | Jan 2015 |
| STAR-TECH AND JRS SPECIALTY PRODUCTS CO LTD China | 28972 | CROSPOVIDONE | Dec 2014 |
| JIAOZUO ZHONGWEI SPECIAL PRODUCTS PHARMACEUTICAL CO LTD | 28408 | CROSPOVIDONE | Jun 2014 |
“Filed as” is the subject exactly as the holder gave it to the FDA, including the grade or pharmacopoeia it names. Holder names link to a company profile where one is published. An active filing can be referenced by a drug application; it is not proof of current supply.
Valid CEPs for this substance (8)
| Holder | Country | Certificate | Issued |
|---|---|---|---|
| BOAI NKY MEDICAL HOLDINGS LTD | CN | R0-CEP 2023-020 - Rev 00 Crospovidone, Type A and B | Aug 2023 |
| CNSG ANHUI HONG SIFANG CO., LTD. Hefei City CN | CN | R1-CEP 2016-264 - Rev 00 Crospovidone, Type B | Jan 2023 |
| JH NANHANG LIFE SCIENCES CO., LTD. Quzhou CN | CN | R1-CEP 2014-157 - Rev 00 Crospovidone, Type A and B | Feb 2021 |
| HUANGSHAN BONSUN PHARMACEUTICALS CO., LTD. Shexian CN | CN | R1-CEP 2014-344 - Rev 00 Crospovidone, Type A and B | Feb 2021 |
| STAR-TECH AND JRS SPECIALTY PRODUCTS CO LTD | CN | R1-CEP 2014-337 - Rev 00 Crospovidone, Type A and B | Nov 2020 |
| JIAOZUO ZHONGWEI SPECIAL PRODUCTS PHARMACEUTICAL CO., LTD. Jiaozuo CN | CN | R1-CEP 2012-195 - Rev 01 Crospovidone, Type A and B | Nov 2019 |
| BASF SE | DE | R1-CEP 2007-076 - Rev 01 Crospovidone, Type A and B | Jun 2015 |
| International Specialty Products Wayne US | US | R1-CEP 2003-224 - Rev 00 Crospovidone | Feb 2011 |
Certification Online Database, European Directorate for the Quality of Medicines & HealthCare. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
What these records establish
- A Type IV DMF is a confidential file held by the FDA for an excipient, colourant or flavour. The FDA does not approve or disapprove it; it is reviewed when a drug application references it.
- Active means the file is open and can be referenced with the holder's letter of authorisation. It says nothing about price, capacity or current availability.
- The holder is the organisation that filed. It is usually, but not always, the manufacturer.
- Many excipients are supplied without any DMF, so this list is not every supplier of Crospovidone.
Do you supply Crospovidone?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.